Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Amylin Pharmaceuticals Inc.

Headquarters: San Diego, CA, United States of America
Website: N/A
Year Founded: 1987
Status: Acquired

BioCentury | Mar 7, 2025
Product Development

Could amylin outshine GLP-1 in obesity?

If the preclinical data translate to the clinic, amylin has a good chance to supplant GLP-1 for the overweight to moderate obesity population
BioCentury | Nov 21, 2024
Finance

Versant-backed Pep2Tango taking four-way agonist to clinic for obesity

Program designed to reduce weight while sparing muscle mass, GI effects headed for IND next year
BioCentury | Jan 18, 2023
Politics, Policy & Law

Hit by the Clinton cyclone

Clintonomic uncertainty slams the window down: BioCentury’s 30th anniversary collection
BioCentury | Apr 29, 2022
Product Development

April 28 Quick Takes: Pfizer enrolling DMD trial after FDA lifts hold

Plus FDA approves AZ’s Ultomiris for gMG and updates from Gilead, Cytovia and more
BioCentury | May 20, 2017
Strategy

Henri: N of 1

How the late Genzyme CEO Henri Termeer created the Orphan drug industry
BioCentury | Mar 8, 2017
Company News

Management tracks

BioCentury | Feb 22, 2017
Company News

BMS gains on investment rumors

BioCentury | Dec 17, 2015
Strategy

San Diego ceiling

New academic leadership in San Diego aims to amp up cluster's translational power
Items per page:
1 - 10 of 751